Balchem Corporation will announce its second quarter 2026 financial results on July 31, 2026, providing investors with an update on its performance across its three business segments. The results will be published before the market opens, with a conference call scheduled for 11:00 AM Eastern Time (ET) the same day to discuss the findings. Ted Harris, Chairman of the Board, President and CEO, and Martin Bengtsson, CFO, will lead the discussion.

The press release and accompanying financial exhibits will be available on the company's website, www.balchem.com , ahead of the conference call. Institutional investors, analysts, and other members of the financial community can join the live call by dialing +1-833-461-5787 (USA/Canada toll free) or +1-585-542-9983 (International Toll), using Meeting ID 980453675. Participants are advised to dial in five minutes before the start time.

A live webcast will be accessible to the public at https://events.q4inc.com/attendee/980453675 . For those unable to attend the live session, a replay of the conference call will be available at the same link for one year following the event.

Balchem Corporation develops, manufactures, and markets specialty ingredients through its three business segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health segment provides ingredient systems and nutrients for the food, supplement, and pharmaceutical industries. The Animal Nutrition & Health segment supplies products to animal health markets, while Specialty Products offers specialty-packaged chemicals and chelated minerals for healthcare and agricultural applications.

Balchem Corporation executives will attend the CJS Securities 26th Annual New Ideas Summer Conference on July 9, 2026. The company, a global specialty ingredient manufacturer for health and nutrition markets, announced that its leadership team will engage with investors during the event.

Ted Harris, Chairman of the Board, President and Chief Executive Officer, will represent Balchem Corporation. He will be accompanied by Martin Bengtsson, Chief Financial Officer, and Allison Baurichter, Senior Director Investor Relations.

Balchem Corporation develops, manufactures and markets specialty ingredients designed to improve health and well-being. The company operates through three primary business segments: Human Nutrition & Health; Animal Nutrition & Health; and Specialty Products.

The Human Nutrition & Health segment provides customized food and beverage ingredient systems and key nutrients for the food, supplement and pharmaceutical industries. The Animal Nutrition & Health segment supplies products to various animal health markets. The Specialty Products segment offers specialty-packaged chemicals for healthcare and other industries, along with chelated minerals for the agricultural market.